|
NSUN7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.419800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.397600E-03 |
| Normal-vs-Stage2 |
7.495500E-03 |
| Normal-vs-Stage3 |
4.29690000000038E-05 |
| Normal-vs-Stage4 |
2.884000E-03 |
| Stage1-vs-Stage2 |
6.651400E-01 |
| Stage1-vs-Stage3 |
6.427800E-02 |
| Stage1-vs-Stage4 |
3.106800E-01 |
| Stage2-vs-Stage3 |
3.723600E-01 |
| Stage2-vs-Stage4 |
6.561000E-01 |
| Stage3-vs-Stage4 |
7.490400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63520000000728E-05 |
| Normal-vs-AfricanAmerican |
1.987580E-01 |
| Normal-vs-Asian |
4.615400E-01 |
| Caucasian-vs-AfricanAmerican |
1.390640E-01 |
| Caucasian-vs-Asian |
2.064000E-02 |
| AfricanAmerican-vs-Asian |
6.333800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.916800E-03 |
| Normal-vs-Female |
3.601800E-04 |
| Male-vs-Female |
3.104400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.194020E-02 |
| Normal-vs-Age(41-60Yrs) |
1.958050E-03 |
| Normal-vs-Age(61-80Yrs) |
1.648440E-04 |
| Normal-vs-Age(81-100Yrs) |
6.661000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.395200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.027020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.929560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.172600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.881600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.687200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.20399999969933E-07 |
| Classical-VS-Follicular |
3.794300E-02 |
| Classical-VS-Other |
3.369600E-02 |
| Classical-VS-Normal |
8.443400E-04 |
| Tall-VS-Follicular |
1.62750000143319E-08 |
| Tall-VS-Other |
2.751600E-02 |
| Tall-VS-Normal |
7.56680273994448E-11 |
| Follicular-VS-Other |
2.247800E-01 |
| Follicular-VS-Normal |
1.891420E-01 |
| Other-VS-Normal |
6.143400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.323000E-03 |
| Normal-vs-N1 |
4.800200E-02 |
| N0-vs-N1 |
9.780200E-01 |
|
|
